Caricamento...
Methotrexate as an oral corticosteroid-sparing agent in severe asthma: the emergence of a responder asthma endotype
BACKGROUND: Sustained use of oral corticosteroids is associated with significant side effects. It is therefore of interest to find a corticosteroid-sparing agent. In two meta-analyses, methotrexate resulted in a rather small reduction in the oral corticosteroid maintenance dose. We have used methotr...
Salvato in:
| Pubblicato in: | Eur Clin Respir J |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Co-Action Publishing
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4629721/ https://ncbi.nlm.nih.gov/pubmed/26557239 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3402/ecrj.v1.25037 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|